- Zai Lab Announces Third Quarter 2023 Financial Results and Recent Corporate Updates
- Zai Lab Announces Participation in November Investor Conferences
- Zai Lab to Announce Third Quarter 2023 Financial Results and Recent Corporate Updates on November 7, 2023
- Zai Lab Obtains Breakthrough Therapy Designation for Efgartigimod Alfa Injection (Subcutaneous Injection) in Patients with Chronic Inflammatory Demyelinating Polyneuropathy in China
- Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib for Treatment of Patients with NTRK-positive TKI-pretreated advanced solid tumors in China
- Zai Lab Announces Participation in September Investor Conferences
- Zai Lab Announces Second Quarter 2023 Financial Results and Corporate Updates
More ▼
Key statistics
On Friday, Zai Lab Ltd (1ZL:DEU) closed at 16.70, 34.68% above the 52 week low of 12.40 set on Apr 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 17.40 |
---|---|
High | 17.40 |
Low | 16.70 |
Bid | 16.90 |
Offer | 17.40 |
Previous close | 17.00 |
Average volume | 94.13 |
---|---|
Shares outstanding | 99.61m |
Free float | 97.44m |
P/E (TTM) | -- |
Market cap | 1.82bn USD |
EPS (TTM) | -3.50 USD |
Data delayed at least 15 minutes, as of Jul 19 2024.
More ▼